Mark Sweeney

1.6k total citations
34 papers, 837 citations indexed

About

Mark Sweeney is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Mark Sweeney has authored 34 papers receiving a total of 837 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 4 papers in Molecular Biology and 3 papers in Surgery. Recurrent topics in Mark Sweeney's work include Cardiovascular Function and Risk Factors (4 papers), Cardiac Fibrosis and Remodeling (4 papers) and Heart Failure Treatment and Management (3 papers). Mark Sweeney is often cited by papers focused on Cardiovascular Function and Risk Factors (4 papers), Cardiac Fibrosis and Remodeling (4 papers) and Heart Failure Treatment and Management (3 papers). Mark Sweeney collaborates with scholars based in United Kingdom, United States and Singapore. Mark Sweeney's co-authors include Stuart A. Cook, Gábor Földes, Ben Corden, Tom A. Gardiner, Ciarán O’Neill, Jasenka Guduric‐Fuchs, Alan W. Stitt, Reinhold J. Medina, David Simpson and Simone Hochgreb and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and British Journal of Pharmacology.

In The Last Decade

Mark Sweeney

32 papers receiving 819 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Sweeney United Kingdom 12 353 238 105 98 92 34 837
Aylit Schultz Canada 5 370 1.0× 216 0.9× 111 1.1× 102 1.0× 117 1.3× 7 745
Christine Mancini United States 13 273 0.8× 502 2.1× 104 1.0× 46 0.5× 131 1.4× 22 1.2k
Liyong Zhang China 15 480 1.4× 202 0.8× 92 0.9× 75 0.8× 337 3.7× 68 1.1k
Joel Wilson United States 11 291 0.8× 518 2.2× 145 1.4× 58 0.6× 133 1.4× 20 1.2k
Daniel F. Freitag Germany 12 331 0.9× 152 0.6× 129 1.2× 25 0.3× 44 0.5× 16 845
Hironori Saito Japan 15 409 1.2× 246 1.0× 150 1.4× 67 0.7× 61 0.7× 40 843
Jianghua Wu China 16 317 0.9× 127 0.5× 72 0.7× 257 2.6× 73 0.8× 68 854
Matthew O’Connor United States 14 352 1.0× 104 0.4× 94 0.9× 185 1.9× 125 1.4× 48 788
Uta Hillebrand Germany 14 248 0.7× 149 0.6× 123 1.2× 33 0.3× 28 0.3× 25 897

Countries citing papers authored by Mark Sweeney

Since Specialization
Citations

This map shows the geographic impact of Mark Sweeney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Sweeney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Sweeney more than expected).

Fields of papers citing papers by Mark Sweeney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Sweeney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Sweeney. The network helps show where Mark Sweeney may publish in the future.

Co-authorship network of co-authors of Mark Sweeney

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Sweeney. A scholar is included among the top collaborators of Mark Sweeney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Sweeney. Mark Sweeney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sweeney, Mark, Michael S. Lee, Henrike Maatz, et al.. (2024). Interleukin 11 therapy causes acute left ventricular dysfunction. Cardiovascular Research. 120(17). 2220–2235. 1 indexed citations
2.
Wall, Matthew B., Rebecca Harding, Rayyan Zafar, et al.. (2024). Neuroimaging and the Investigation of Drug-Drug Interactions Involving Psychedelics. SHILAP Revista de lepidopterología. 19. 2318914422–2318914422.
3.
Zaman, Sameer, Nicholas M. Quaife, Mark Sweeney, et al.. (2023). Smartphone-Based Remote Monitoring for Chronic Heart Failure: Mixed Methods Analysis of User Experience From Patient and Nurse Perspectives. SHILAP Revista de lepidopterología. 6. e44630–e44630. 7 indexed citations
4.
Zaman, Sameer, Nicholas M. Quaife, Mark Sweeney, et al.. (2023). Smartphone-Based Remote Monitoring in Heart Failure With Reduced Ejection Fraction: Retrospective Cohort Study of Secondary Care Use and Costs. JMIR Cardio. 7. e45611–e45611. 4 indexed citations
5.
Sweeney, Mark, Michael Lee, Konstantinos Vanezis, et al.. (2023). Cardiomyocyte-Restricted Expression of IL11 Causes Cardiac Fibrosis, Inflammation, and Dysfunction. International Journal of Molecular Sciences. 24(16). 12989–12989. 15 indexed citations
6.
Cannatà, Antonio, Mark Sweeney, Rosita Zakeri, et al.. (2023). The Prognostic Impact of Specialist Cardiology Input in Patients Admitted for Heart Failure and Normal Ejection Fraction. ESC Heart Failure. 10(4). 2648–2655. 4 indexed citations
7.
Osimo, Emanuele F., Mark Sweeney, Antonio de Marvao, et al.. (2021). Adipose tissue dysfunction, inflammation, and insulin resistance: alternative pathways to cardiac remodelling in schizophrenia. A multimodal, case–control study. Translational Psychiatry. 11(1). 614–614. 15 indexed citations
8.
Sweeney, Mark, Graham D. Cole, Punam Pabari, et al.. (2021). Urinary Drug Metabolite Testing in Chronic Heart Failure Patients Indicates High Levels of Adherence with Life-Prolonging Therapies. ESC Heart Failure. 8(3). 2334–2337. 2 indexed citations
9.
Sweeney, Mark, et al.. (2021). Geriatrician-led care model in frail cardiology patients reduces re-admissions. Future Healthcare Journal. 8(2). e299–e301. 1 indexed citations
10.
Sweeney, Mark, Ben Corden, & Stuart A. Cook. (2020). Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?. EMBO Molecular Medicine. 12(10). e10865–e10865. 127 indexed citations
11.
Sweeney, Mark, et al.. (2020). The impact of an acute chest pain pathway on the investigation and management of cardiac chest pain. Future Healthcare Journal. 7(1). 53–59. 11 indexed citations
12.
Sweeney, Mark. (2020). Counseling clients during New York City’s COVID-19 pandemic: observations on fundamental elements of emotions management. Irish Journal of Psychological Medicine. 37(3). 212–213. 2 indexed citations
13.
Patel, Rishi, Alice Moore, Susan Piper, et al.. (2019). Clozapine and cardiotoxicity – A guide for psychiatrists written by cardiologists. Psychiatry Research. 282. 112491–112491. 30 indexed citations
14.
Sweeney, Mark, Eromona Whiskey, Rishi Patel, et al.. (2019). Understanding and managing cardiac side-effects of second-generation antipsychotics in the treatment of schizophrenia. BJPsych Advances. 26(1). 26–40. 7 indexed citations
15.
Sweeney, Mark & Gábor Földes. (2018). It Takes Two: Endothelial-Perivascular Cell Cross-Talk in Vascular Development and Disease. Frontiers in Cardiovascular Medicine. 5. 154–154. 121 indexed citations
16.
Sweeney, Mark, et al.. (2017). Cardiac Atrophy and Heart Failure In Cancer. Cardiac failure review. 3(1). 62–62. 31 indexed citations
17.
Sweeney, Mark & Simone Hochgreb. (2009). Autonomous extraction of optimal flame fronts in OH planar laser-induced fluorescence images. Applied Optics. 48(19). 3866–3866. 34 indexed citations
18.
Sweeney, Mark, Robert S. Barlow, & Simone Hochgreb. (2008). Technical Drawings of Cambridge Stratified Swirl Burner (SwB). Apollo (University of Cambridge). 3 indexed citations
19.
Papastamatiou, D., et al.. (1993). Earthquake response at Grangemouth. Géotechnique. 43(4). 537–553. 2 indexed citations
20.
Sweeney, Mark, et al.. (1992). Transfusion practices and costs in dogs. Journal of the American Veterinary Medical Association. 201(11). 1697–1701. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aylit Schultz Breakdown of academic impact, for papers by Christine Mancini Breakdown of academic impact, for papers by Liyong Zhang Breakdown of academic impact, for papers by Joel Wilson Breakdown of academic impact, for papers by Daniel F. Freitag Breakdown of academic impact, for papers by Hironori Saito Breakdown of academic impact, for papers by Jianghua Wu Breakdown of academic impact, for papers by Matthew O’Connor Breakdown of academic impact, for papers by Uta Hillebrand
Rankless by CCL
2026